Abiopharma

New Form 3 - NEOGENOMICS INC Filed: 2026-01-05 AccNo: 0001628280-26-000705 Size: 403 KB

Gonzalez Patricia Paola 🟢 acquired 263 shares (1 derivative) of ABBOTT LABORATORIES (ABT) Transaction Date: Dec 31, 2025 | Filing ID: 000002

Director Kenny John P. 🟢 acquired 10.1K shares (2 derivative) of NEOGENOMICS INC (NEO) at $11.76 Transaction Date: Jan 01, 2026 | Filing ID: 000706

Sachs David C. 🟡 adjusted position in 15.4K shares (1 derivative) of ImmunityBio, Inc. (IBRX) at $1.98 Transaction Date: Dec 31, 2025 | Filing ID: 000001

BAKER G LEONARD JR 🔴 sold 0 shares of CORCEPT THERAPEUTICS INC (CORT) Transaction Date: Jan 01, 2026 | Filing ID: 000003

Director Adcock Richard 🟡 adjusted position in 17.5K shares (1 derivative) of ImmunityBio, Inc. (IBRX) at $1.98 Transaction Date: Dec 31, 2025 | Filing ID: 000001

Westlake refuerza su cartera global de soluciones de compuestos con la adquisición del negocio de soluciones de formulación de compuestos de ACI

New Form SCHEDULE 13D/A - EXELIXIS, INC. Filed: 2026-01-05 AccNo: 0000908834-26-000006 Size: 724 KB

Director Zinman Jon 🟡 adjusted position in 0 shares (1 derivative) of Keenova Therapeutics plc (NONE) Transaction Date: Jan 01, 2026 | Filing ID: 000785

Tyndall Mark Anthony 🟡 adjusted position in 2.1K shares (1 derivative) of Keenova Therapeutics plc (NONE) Transaction Date: Jan 01, 2026 | Filing ID: 000784

ONeill Hugh Paul 🟡 adjusted position in 1.1K shares (1 derivative) of Keenova Therapeutics plc (NONE) Transaction Date: Jan 01, 2026 | Filing ID: 000783

Director Olafsson Sigurdur O 🟡 adjusted position in 16.9K shares (1 derivative) of Keenova Therapeutics plc (NONE) Transaction Date: Jan 01, 2026 | Filing ID: 000782

Nielsen Henriette 🟡 adjusted position in 2.4K shares (1 derivative) of Keenova Therapeutics plc (NONE) Transaction Date: Jan 01, 2026 | Filing ID: 000781

French Lisa 🟡 adjusted position in 2.0K shares (1 derivative) of Keenova Therapeutics plc (NONE) Transaction Date: Jan 01, 2026 | Filing ID: 000780

Saia John G. 🟡 adjusted position in 17.8K shares (6 derivative) of Guardant Health, Inc. (GH) at $102.14 ($1.0M) Transaction Date: Jan 01, 2026 | Filing ID: 000002